7 studies were found.

1.		No longer recruiting	12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy. Condition: Hepatitis C
2.		No longer recruiting	A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients with Ovarian Epithelial Carcinoma Condition: Ovarian Neoplasms
3.		Terminated	Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft Condition: Peripheral Vascular Disease
4.		No longer recruiting	Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-chemotherapy Consolidation for Ovarian Carcinoma Condition: Ovarian Neoplasms
5.		Recruiting	Phase III Randomized Study of UT-15 in Patients with Primary Pulmonary Hypertension Condition: Pulmonary Hypertension
6.		Terminated	Study of Remodulin in Patients with Critical Limb Ischemia With No Planned Revascularization Procedures Conditions: Critical Limb Ischemia; Peripheral Vascular Disease; Foot Ulcers; Rest Leg Pain
7.		Recruiting	A Transition Study From Flolan® to Remodulin® in Patients with Pulmonary Arterial Hypertension Conditions: Pulmonary Arterial Hypertension; Pulmonary Hypertension